These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11981279)

  • 21. Advances in radiotherapy of head and neck cancers.
    Tao Y; Daly-Schveitzer N; Lusinchi A; Bourhis J
    Curr Opin Oncol; 2010 May; 22(3):194-9. PubMed ID: 20401975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cisplatin combinations in the treatment of head and neck cancer.
    al-Sarraf M
    Semin Oncol; 1994 Oct; 21(5 Suppl 12):28-34. PubMed ID: 7992064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensive chemoradiotherapy as a primary treatment for organ preservation in patients with advanced cancer of the head and neck: efficacy, toxic effects, and limitations.
    Hanna E; Alexiou M; Morgan J; Badley J; Maddox AM; Penagaricano J; Fan CY; Breau R; Suen J
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):861-7. PubMed ID: 15262764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.
    Haddad R; O'Neill A; Rabinowits G; Tishler R; Khuri F; Adkins D; Clark J; Sarlis N; Lorch J; Beitler JJ; Limaye S; Riley S; Posner M
    Lancet Oncol; 2013 Mar; 14(3):257-64. PubMed ID: 23414589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integration of chemotherapy in the curative treatment of locally advanced head and neck cancer.
    Haddad RI; Wirth L; Posner MR
    Expert Rev Anticancer Ther; 2003 Jun; 3(3):331-8. PubMed ID: 12820776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
    Vokes EE; Weichselbaum RR; Mick R; McEvilly JM; Haraf DJ; Panje WR
    J Natl Cancer Inst; 1992 Jun; 84(11):877-82. PubMed ID: 1375657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Revisiting induction chemotherapy for head and neck cancer. References and reviews.
    Argiris A; Jayaram P; Pichardo D
    Oncology (Williston Park); 2005 Jun; 19(7):932-4, 939; discussion 939-45. PubMed ID: 16053039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant chemotherapy of head and neck cancer: the past, the present, and the future.
    Choksi AJ; Dimery IW; Hong WK
    Semin Oncol; 1988 Jun; 15(3 Suppl 3):45-59. PubMed ID: 3293216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revisiting induction chemotherapy for head and neck cancer.
    Argiris A; Jayaram P; Pichardo D
    Oncology (Williston Park); 2005 May; 19(6):759-70. PubMed ID: 15971451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction therapy in the modern era of combined-modality therapy for locally advanced head and neck cancer.
    Posner M; Vermorken JB
    Semin Oncol; 2008 Jun; 35(3):221-8. PubMed ID: 18544437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How much radiation is the chemotherapy worth in advanced head and neck cancer?
    Kasibhatla M; Kirkpatrick JP; Brizel DM
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1491-5. PubMed ID: 17674979
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction chemotherapy with TPF (Docetaxel, Carboplatin and Fluorouracil) in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Schultz JD; Bran G; Anders C; Sadick H; Faber A; Hörmann K; Sauter A
    Oncol Rep; 2010 Nov; 24(5):1213-6. PubMed ID: 20878112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Development of treatments for head and neck squamous cell carcinomas].
    Tsukuda M
    Gan To Kagaku Ryoho; 1999 Jun; 26 Suppl 1():85-96. PubMed ID: 10410663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concomitant chemoradiotherapy for advanced head and neck cancer.
    Lin JC; Jan JS; Hsu CY
    Jpn J Clin Oncol; 1994 Apr; 24(2):94-100. PubMed ID: 8158863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Head and neck cancer: guidelines for chemotherapy.
    Catimel G
    Drugs; 1996 Jan; 51(1):73-88. PubMed ID: 8741233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent randomized trials of chemoradiation in the management of locally advanced head and neck cancer.
    Adelstein DJ
    Curr Opin Oncol; 1998 May; 10(3):213-8. PubMed ID: 9619357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck.
    Budach W; Hehr T; Budach V; Belka C; Dietz K
    BMC Cancer; 2006 Jan; 6():28. PubMed ID: 16448551
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: clinical response and organ/function preservation.
    Mantovani G; Macciò A; Massa E; Mulas C; Mudu MC; Massidda S; Massa D; Murgia V; Ferreli L; Succu G; Astara G; Proto E; Tore G; Mura M; Maxia G
    Oncol Rep; 1999; 6(6):1425-30. PubMed ID: 10523724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiotherapy for cancer of the head and neck: altered fractionation regimens.
    Nguyen LN; Ang KK
    Lancet Oncol; 2002 Nov; 3(11):693-701. PubMed ID: 12424072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.